The Lancet: November 22, 2012
David Cunningham from the Royal Marsden Hospital in London assesses the potential of regorafenib in the treatment of colorectal cancer and gastrointestinal stromal tumours. (Source: Listen to The Lancet)
Source: Listen to The Lancet - November 22, 2012 Category: Journals (General) Authors: The Lancet Source Type: podcasts